Nitto-denko Corporation

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

Sazzadur Rahman Khan

Amane Mochizuki

Shijun Zheng

Sheng Li

David T Sisk

Liping Ma

Kazunori Mune

Brett T Harding

Hiep Luu

Hyunsik Chae

Noriyuki Juni

Qianxi Lai

Rebecca Romero

Visit Thaveeprungsriporn

Ekambaram Sambandan

Toshiki Naito

Hiroyuki Katayama

Takuya Fukumura

Jensen Cayas

Juanita Josephine Anders

Hyun Sik Chae

Yutaka Aoki

Keisaku Okada

Xingjia Wu

Rebecca Bottger

Szuhan Hu

Described herein are liquid crystal compositions that can allow for the adjustment of their refractive indices by the application of an electric field. Also described herein are liquid crystal mixtures containing these compositions. In addition, selectively dimmable reverse-mode polymer dispersed liquid crystal (PDLC) elements and devices using these compositions are also described, which are transparent when no or low voltage is applied and opaque when a voltage or high voltage is applied.

Liquid crystal compositions, mixtures, elements, and dimmable devices

Described herein are liquid crystal compositions containing a five-member heterocyclic ring that can allow for the adjustment of their refractive indices under the application of an electric field. In addition, selectively dimmable reverse-mode polymer dispersed liquid crystal elements and devices using the aforementioned compositions are also described, which are transparent when no voltage is applied and opaque when a voltage is applied.

Liquid crystal composition containing a five-membered heterocyclic ring, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device

Heterocyclic liquid crystal compositions that can allow for the adjustment of their refractive indices by the application of an electric field, such as those described by the following formula: are disclosed. Also disclosed are selectively dimmable reverse-mode polymer dispersed liquid crystal (PDLC) elements and devices using the aforementioned compositions, which are transparent when no voltage is applied and opaque when a voltage is applied.

Heterocyclic liquid crystal composition, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device

Described herein are heterocyclic liquid crystal compositions that can allow for the adjustment of their refractive indices by the application of an electric field. In addition, selectively dimmable reverse-mode polymer dispersed liquid crystal (PDLC) elements and devices using these compositions are also described, which are transparent when no voltage is applied and opaque when a voltage is applied.

Heterocyclic liquid crystal composition, reverse-mode polymer dispersed liquid crystal element, and selectively dimmable device

Described herein are liquid crystal compositions and derivative mixtures thereof that can allow for the adjustment of their refractive indices by the application of an electric field. In addition, selectively dimmable reverse-mode polymer dispersed liquid crystal (PDLC) elements and devices using the aforementioned compositions are also described, which are transparent when no voltage is applied and opaque when a voltage is applied.

Liquid crystal composition, liquid crystal mixture, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device

A photocatalytic element including: a photocatalytic layer containing at least one photocatalytic material; and a light emitting source in optical communication with the photocatalytic material, the light emitting source disposed sufficiently proximal to the photocatalytic material to raise the surface temperature of at least some of the photocatalytic material to a temperature between 10&#xb0; C. and 90&#xb0; C. is provided.

Photocatalytic element

Methods and devices related to wound healing using phototherapy are described. Some embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising Ring System 1, Ring System 2, Ring System 3, Ring System 4 or Ring System 5.

Light-emitting devices for wound healing

Polyphenylene compounds such as compounds represented by Formula 1 may be used in electronic devices such as organic light-emitting devices. For example, the compounds may be used as host materials in a light-emitting layer.

Polyphenylene host compounds

Included herein is the compound: and related compounds, and light-emitting devices comprising the same.

Compounds for use in light-emitting devices

Optionally substituted bipyridine compounds, optionally substituted phenylbipyridine compounds, or optionally substituted bis-phenylbipyridine compounds may be useful in light-emitting devices. Some examples include, but are not limited to, optionally substituted 4-(5-(6-(4-(diphenylamino)phenyl)pyridin-3-yl)pyridin-2-yl)-N,N-diphenylbenzenamine, optionally substituted 9-(4-(5-(6-(4-(9H-carbazol-9-yl)phenyl)pyridin-3-yl)pyridin-2-yl)phenyl)-9H-carbazole, optionally substituted 4-(5-(6-(benzo[d]thiazol-2-yl)pyridin-3-yl)pyridin-2-yl)-N,N-diphenylbenzenamine, optionally substituted 4-(5-(6-(benzo[d]oxazol-2-yl)pyridin-3-yl)pyridin-2-yl)-N,N-diphenylbenzenamine, optionally substituted N,N-diphenyl-4-(5-(6-(1-phenyl-1H-benzo[d]imidazol-2-yl)pyridin-3-yl)pyridin-2-yl)benzenamine, optionally substituted 4-(5-(6-(4-(9H-carbazol-9-yl)phenyl)pyridin-3-yl)pyridin-2-yl)-N,N-diphenylbenzenamine, optionally substituted 2-(5-(6-(benzo[d]thiazol-2-yl)pyridin-3-yl)pyridin-2-yl)benzo[d]thiazole, optionally substituted 2-(5-(6-(benzo[d]thiazol-2-yl)pyridin-3-yl)pyridin-2-yl)benzo[d]oxazole, optionally substituted 9-(4-(5-(6-(benzo[d]thiazol-2-yl)pyridin-3-yl)pyridin-2-yl)phenyl)-9H-carbazole, optionally substituted 9-(4-(5-(6-(benzo[d]oxazol-2-yl)pyridin-3-yl)pyridin-2-yl)phenyl)-9H-carbazole, optionally substituted 9-(4-(6'-(1-phenyl-1H-benzo[d]imidazol-2-yl)-3,3&#x2032;-bipyridin-6-yl)phenyl)-9H-carbazole, and 6,6&#x2032;-bis(9-phenyl-9H-carbazol-3-yl)-3,3&#x2032;-bipyridine.

Substituted bipyridines for use in organic light-emitting devices

Polyphenylene compounds such as compounds represented by Formula I may be used in electronic devices such as organic light-emitting devices. For example, the compounds may be used as host materials in a light-emitting layer.

Methods and devices related to the treatment of diseases using phototherapy are described. Some embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising Ring system, Ring system, Ring system, or Ring system. Methods of treating disease with phototherapy are also described.

Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds

Methods and devices related to the treatment of diseases using phototherapy are described. Some embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising a compound of Formula 1. Methods of treating disease diseases with phototherapy are also described.

Phototherapy devices and methods comprising substituted carbazole compounds

An optical waveguide device which is free from interference with an optical path between a light emitting element and an optical waveguide thereof, and to provide a method of manufacturing the optical waveguide device. A light emitting element () is provided on an upper surface of a first under-cladding layer (), and a second under-cladding layer () is provided on the upper surface of the first under-cladding layer (), covering the light emitting element (). A corewhich receives light emitted from the light emitting element () through the second under-cladding layer () is provided on an upper surface of the second under-cladding layer (). The core () is located in a position such that the light emitted from the light emitting element () is incident on the core ().

Growing community of inventors

San Diego, CA, United States of America

Sazzadur Rahman Khan